STOCK TITAN

Zynex (ZYXIQ) Stock Price, News & Analysis

ZYXIQ

Zynex (ZYXIQ) last traded on March 26, 2026. A Form 15-12G filed on March 26, 2026 ends the SEC registration of its shares.

Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
42 63 sessions, December 24, 2025 to March 26, 2026
Largest daily move
+91.1% close of February 20, 2026
1-month change
-38.9% closing prices, February 26, 2026 to March 26, 2026

Company Description

Zynex (ZYXIQ) is classified in the medical distribution industry within the Healthcare sector.

ZYXIQ declined 56.3% in the year to March 26, 2026. The last closing price was $0.0550.

For FY2024, Zynex reported revenue of $192.4M with net income of $3.0M and diluted earnings per share of $0.09. The company operates at a net profit margin of 1.6%.

This page collects what Stock Titan holds for ZYXIQ, including price data, latest news, SEC filings, financial highlights, and short interest trends.

Stock Performance

$0.0550
No recent trading
Last close: March 26, 2026
-56.3%
Year to March 26, 2026

Zynex (ZYXIQ) closed at $0.0550 on March 26, 2026. In the year to March 26, 2026, the price lost 56.3%.

See what a $1,000 investment in ZYXIQ would be worth today

Average down calculator for ZYXIQ

ZYXIQ Metrics & Rankings

Price returns through March 26, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Zynex has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all ZYXIQ news →

Financial Highlights

Zynex generated $192.4M in revenue in FY2024, retaining a 79.5% gross margin, operating income reached $6.0M (3.1% operating margin), and net income was $3.0M, reflecting a 1.6% net profit margin. Diluted earnings per share stood at $0.09. The company generated $12.7M in operating cash flow. The current ratio was 4.46, measuring current assets divided by current liabilities.

$192.4M
Revenue (FY2024)
$3.0M
Net Income (FY2024)
$12.7M
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for ZYXIQ.

Short Interest History

Last 12 Months

Short interest in Zynex (ZYXIQ) currently stands at 1.2 million shares, up 1.0% from the previous reporting period, representing 7.5% of the float. Since December 2025, short interest has decreased by 36.7%.

Days to Cover History

Last 12 Months

Days to cover for Zynex (ZYXIQ) currently stands at 7.8 days, up 75.9% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since December 2025, the figure has increased by 681%. Across the settlements charted above, it has ranged from 1.0 to 9.1 days.

ZYXIQ Company Profile & Sector Positioning

Zynex (ZYXIQ) operates in the Medical Distribution industry within the broader Healthcare sector.

Investors comparing ZYXIQ often look at related companies in the same sector, including Amplifon SPA (AMFPY), Gold Entmt Group Inc (GEGP), Nass VY Gateway Ltd (NSVGF), Essilor Lxttca (ESLOY), and Siemens Healthineers (SMMNY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ZYXIQ's relative position within its industry.

Frequently Asked Questions

Zynex (ZYXIQ) last traded on March 26, 2026. A Form 15-12G filed on March 26, 2026 ends the SEC registration of its shares.

Zynex (ZYXIQ) has no recent trading. Its last close was $0.0550 on March 26, 2026.

The FY2024 revenue of Zynex (ZYXIQ) is $192.4M, from its most recent completed fiscal year.

The FY2024 net income of Zynex (ZYXIQ) is $3.0M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Zynex (ZYXIQ) is $0.09 for FY2024, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Zynex (ZYXIQ) is $12.7M for FY2024, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Zynex (ZYXIQ) is 1.6% for FY2024, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Zynex (ZYXIQ) is 3.1% for FY2024, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of Zynex (ZYXIQ) is 79.5% for FY2024, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Zynex (ZYXIQ), current assets divided by current liabilities, was 4.46 at the end of FY2024, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Zynex (ZYXIQ) is $152.9M for FY2024, its most recent completed fiscal year.

The operating income of Zynex (ZYXIQ) is $6.0M for FY2024, its most recent completed fiscal year. Learn about operating income.